Comparison of Target Enrichment Platforms for Circulating Tumor DNA Detection
Authors:
Open Access
- 5 March 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-12
Abstract
Cancer-related mortality of solid tumors remains the major cause of death worldwide. Circulating tumor DNA (ctDNA) released from cancer cells harbors specific somatic mutations. Sequencing ctDNA opens opportunities to non-invasive population screening and lays foundations for personalized therapy. In this study, two commercially available platforms, Roche’s Avenio ctDNA Expanded panel and QIAgen’s QIAseq Human Comprehensive Cancer panel were compared for (1) panel coverage of clinically relevant variants; (2) target enrichment specificity and sequencing performance; (3) the sensitivity; (4) concordance and (5) sequencing coverage using the same human blood sample with ultra-deep next-generation sequencing. Our finding suggests that Avenio detected somatic mutations in common cancers in over 70% of patients while QIAseq covered nearly 90% with a higher average number of variants per patient (Avenio: 3; QIAseq: 8 variants per patient). Both panels demonstrated similar on-target rate and percentage of reads mapped. However, Avenio had more uniform sequencing coverage across regions with different GC content. Avenio had a higher sensitivity and concordance compared with QIAseq at the same sequencing depth. This study identifies a unique niche for the application of each of the panel and allows the scientific community to make an informed decision on the technologies to meet research or application needs.Keywords
This publication has 42 references indexed in Scilit:
- Digital RNA sequencing minimizes sequence-dependent bias and amplification noise with optimized single-molecule barcodesProceedings of the National Academy of Sciences, 2012
- Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer IDProceedings of the National Academy of Sciences, 2011
- Detection and quantification of rare mutations with massively parallel sequencingProceedings of the National Academy of Sciences, 2011
- Cell-free nucleic acids as biomarkers in cancer patientsNature Reviews Cancer, 2011
- Counting individual DNA molecules by the stochastic attachment of diverse labelsProceedings of the National Academy of Sciences, 2011
- A method for counting PCR template molecules with application to next-generation sequencingNucleic Acids Research, 2011
- Detection of PIK3CA mutations in circulating free DNA in patients with breast cancerBreast Cancer Research and Treatment, 2010
- Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal bloodProceedings of the National Academy of Sciences, 2008
- Utilization of an in vitro assay to evaluate chromatin degradation by candidate apoptotic nucleasesCell Death & Differentiation, 1997
- Chromatin sub-structure. The digestion of chromatin DNA at regularly spaced sites by a nuclear deoxyribonucleaseBiochemical and Biophysical Research Communications, 1973